Mechanisms of leukocyte migration across the blood-retina barrier

Seminars in Immunopathology

Volumn 30, Issue 2, 2008, Pages 165-177

  Crane, Isabel J ^a   Liversidge, Janet ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Blood retina barrier; Chemokines; Inflammation; Integrins; Leukocytes; Lymphocytes; Monocytes; Retinal pigment epithelium; Selectins; Tight junctions; Uveitis

Indexed keywords

CHEMOKINE; INTEGRIN;

ANGIOGENESIS; BLOOD RETINA BARRIER; CELL ADHESION; CELL MIGRATION; EPITHELIUM CELL; IMMUNITY; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; RETINA DISEASE; REVIEW;

ANIMALS; BLOOD-RETINAL BARRIER; CHEMOTAXIS, LEUKOCYTE; HUMANS;

EID: 42449110295     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-008-0106-7     Document Type: Review

References (143)

1. Abbott NJ (2002) Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat 200:629-638
2. Abbott NJ, Ronnback L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7:41-53
3. Adamson P, Wilbourn B, Etienne-Manneville S, Calder V, Beraud E, Milligan G, Couraud PO, Greenwood J (2002) Lymphocyte trafficking through the blood-brain barrier is dependent on endothelial cell heterotrimeric G-protein signaling. FASEB J 16:1185-1194
4. Albini TA, Wang RC, Reiser B, Zamir E, Wu GS, Rao NA (2005) Microglial stability and repopulation in the retina. Br J Ophthalmol 89:901-903
5. Ali S, Palmer ACV, Banerjee B, Fritchley SJ, Kirby JA (2000) Examination of the function of RANTES, MIP-1 alpha, and MIP-1 beta following interaction with heparin-like glycosaminoglycans. J Biol Chem 275:11721-11727
6. Alon R, Feigelson S (2002) From rolling to arrest on blood vessels: leukocyte tap dancing on endothelial integrin ligands and chemokines at sub-second contacts. Semin Immunol 14:93-104
7. Bacon K, Baggiolini M, Broxmeyer H, Horuk R, Lindley I, Mantovani A, Matsushima K, Murphy P, Nomiyama H, Oppenheim J, Rot A, Schall T, Tsang M, Thorpe R, Van Damme J, Wadhwa M, Yoshie O, Zlotnik A, Zoon K (2002) Chemokine/chemokine receptor nomenclature. J Interferon Cytokine Res 22:1067-1068
8. Baggiolini M, Dewald B, Moser B (1997) Human chemokines: an update. Annu Rev Immunol 15:675-705
9. Bakker AB, Hoek RM, Cerwenka A, Blom B, Lucian L, McNeil T, Murray R, Phillips LH, Sedgwick JD, Lanier LL (2000) DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 13:345-353
10. Banerjee S, Savant V, Scott RA, Curnow SJ, Wallace GR, Murray PI (2007) Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders. Invest Ophthalmol Vis Sci 48:2203-2207
11. Cai J, Jiang WG, Ahmed A, Boulton M (2006) Vascular endothelial growth factor-induced endothelial cell proliferation is regulated by interaction between VEGFR-2, SH-PTP1 and eNOS. Microvasc Res 71:20-31
12. Callahan MK, Ransohoff RM (2004) Analysis of leukocyte extravasation across the blood-brain barrier: conceptual and technical aspects. Curr Allergy Asthma Rep 4:65-73
13. Campbell JJ, Foxman EF, Butcher EC (1997) Chemoattractant receptor cross talk as a regulatory mechanism in leukocyte adhesion and migration. Eur J Immunol 27:2571-2578
14. Campbell M, Collery R, McEvoy A, Gardiner TA, Stitt AW, Brankin B (2006) Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function. Curr Eye Res 31:1033-1045
15. Caspi RR (2006) Ocular autoimmunity: the price of privilege? Immunol Rev 213:23-35
16. Caspi RR, Chan C-C, Wiggert B, Chader GJ (1990) The mouse as a model of experimental autoimmune uveoretinitis (EAU). Curr Eye Res 9:169-174
17. Caspi RR, Roberge FG, Chan C, Wiggert B, Chader GJ, Rozenszajn LA, Lando Z, Nussenblatt RB (1988) A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J Immunol 140:1490-1495
18. Caspi RR, Silver PB, Chan C-C, Sun B, Agarwal RK, Wells J, Oddo S, Fujino Y, Najafian F, Wilder RL (1996) Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response. J Immunol 157:2668-2675
19. Chakravarthy U, Stitt AW, McNally J, Bailie JR, Hoey EM, Duprex P (1995) Nitric oxide synthase activity and expression in retinal capillary endothelial cells and pericytes. Curr Eye Res 14:285-294
20. Chan JR, Hyduk SJ, Cybulsky MI (2001) Chemoattractants induce a rapid and transient upregulation of monocyte alpha 4 integrin affinity for vascular cell adhesion molecule 1 which mediates arrest: an early step in the process of emigration. J Exp Med 193:1149-1158
21. Chen J, Smith LE (2007) Retinopathy of prematurity. Angiogenesis 10:133-140
22. Chensue SW (2001) Molecular machinations: chemokine signals in host-pathogen interactions. Clin Microbiol Rev 14:821-835
23. Cinamon G, Grabovsky V, Winter E, Franitza S, Feigelson S, Shamri R, Dwir O, Alon R (2001) Novel chemokine functions in lymphocyte migration through vascular endothelium under shear flow. J Leukoc Biol 69:860-866
24. Cinamon G, Shinder V, Alon R (2001) Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines. Nat Immunol 2:515-522
25. Combadiere C, Potteaux S, Gao JL, Esposito B, Casanova S, Lee EJ, Debre P, Tedgui A, Murphy PM, Mallat Z (2003) Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation 107:1009-1016
26. Constantin G, Majeed M, Giagulli C, Piccio L, Kim JY, Butcher EC, Laudanna C (2000) Chemokines trigger immediate beta 2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow. Immunity 13:759-769
27. Crane IJ, Forrester JV (2005) Th1 and Th2 lymphocytes in autoimmune disease. Crit Rev Immunol 25:75-102
28. Crane IJ, McKillop-Smith S, Wallace CA, Lamont GR, Forrester JV (2001) Expression of the chemokines MIP-1a, MCP-1 and RANTES in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci 42:1547-1552
29. Crane IJ, Wallace CA, McKillop-Smith S, Forrester JV (2000) Control of chemokine production at the blood-retina barrier. Immunology 101:426-433
30. Crane IJ, Xu H, Manivannan A, McKillop-Smith S, Lamont G, Wallace C, Sharp PF, Forrester JV (2003) Effect of anti-macrophage inflammatory protein-1a on leukocyte trafficking and disease progression in experimental autoimmune uveoretinitis. Eur J Immunol 33:402-410
31. Crane IJ, Xu H, Wallace C, Manivannan A, Mack M, Liversidge J, Marquez G, Sharp P, Forrester JV (2006) Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis. J Leukoc Biol 79:435-443
32. D'Amico G, Frascaroli G, Bianchi G, Transidico P, Doni A, Vecchi A, Sozzani S, Allavena P, Mantovani A (2000) Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Nat Immunol 1:387-391
33. Daniele LL, Adams RH, Durante DE, Pugh EN Jr, Philp NJ (2007) Novel distribution of junctional adhesion molecule-C in the neural retina and retinal pigment epithelium. J Comp Neurol 505:166-176
34. DeGrendele HC, Estess P, Picker LJ, Siegelman MH (1996) CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway. J Exp Med 183:1119-1130
35. DeGrendele HC, Estess P, Siegelman MH (1997) Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 278:672-675
36. Devaney JM, Greene CM, Taggart CC, Carroll TP, O'Neill SJ, McElvaney NG (2003) Neutrophil elastase up-regulates interleukin-8 via toll-like receptor 4. FEBS Lett 544:129-132
37. Devine L, Lightman SL, Greenwood J (1996) Role of LFA-1, ICAM-1, VLA-4 and VCAM-1 in lymphocyte migration across retinal pigment epithelial monolayers in vitro. Immunology 88:456-462
38. Dick AD, McMenamin PG, Korner H, Scallon BJ, Ghrayeb J, Forrester JV, Sedgwick JD (1996) Inhibition of tumour necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina. Eur J Immunol 26:1018-1025
39. Diedrichs-Mohring M, Nelson PJ, Proudfoot AEI, Thurau SR, Wildner G (2005) The effect of the CC chemokine receptor antagonist Met-RANTES on experimental autoimmune uveitis and oral tolerance. J Neuroimmunol 164:22-30
40. Dua HS, McKinnon A, McMenamin PG, Forrester JV (1991) Ultrastructural pathology of the 'barrier sites' in experimental autoimmune uveitis and experimental autoimmune pinealitis. Br J Ophthalmol 75:391-397
41. Elner VM, Burnstine MA, Strieter RM, Kunkel SL, Elner SG (1997) Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: immunochemical and in-situ hybridization analyses. Exp Eye Res 65:781-789
42. Elner SG, DelMonte D, Bian ZM, Lukacs NW, Elner VM (2006) Differential expression of retinal pigment epithelium (RPE) IP-10 and interleukin-8. Exp Eye Res 83:374-379
43. Emmelkamp JM, Rockstroh JK (2007) CCR5 antagonists: comparison of efficacy, side effects, pharmacokinetics and interactions-review of the literature. Eur J Med Res 12:409-417
44. Engelhardt B, Ransohoff RM (2005) The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol 26:485-495
45. Engelhardt B, Wolburg H (2004) Mini-review: transendothelial migration of leukocytes: through the front door or around the side of the house? Eur J Immunol 34:2955-2963
46. Erickson KK, Sundstrom JM, Antonetti DA (2007) Vascular permeability in ocular disease and the role of tight junctions. Angiogenesis 10:103-117
47. 3CR1. Kidney Int 56:612-620
48. Feria M, Diaz-Gonzalez F (2006) The CCR2 receptor as a therapeutic target. Expert Opin Ther Pat 16:49-57
49. Forrester JV (2000) Autoimmunity and autoimmune diseases of the eye. In: Pleyer U, Zierhut M, Behrens-Baumann W (eds) Immuno-ophthalmology, Dev Ophthalmol. Karger, Basel, pp 167-185
50. Forrester JV, Liversidge W, Dua HS, Dick A, Harper F, McMenamin PG (1992) Experimental autoimmune uveoretinitis: a model system for immunointervention: a review. Curr Eye Res 11:33-40
51. Foxman EF, Zhang MF, Hurst SD, Muchamuel T, Shen DF, Wawrousek EF, Chan CC, Gery I (2002) Inflammatory mediators in uveitis: differential induction of cytokines and chemokines in Th1-versus Th2-mediated ocular inflammation. J Immunol 168:2483-2492
52. Gardner TW, Antonetti DA, Barber AJ, LaNoue KF, Levison SW (2002) Diabetic retinopathy: more than meets the eye. Surv Ophthalmol 47(Suppl 2):S253-S262
53. Ge S, Song L, Pachter JS (2005) Where is the blood-brain barrier... really? J Neurosci Res 79:421-427
54. Gegg ME, Harry R, Hankey D, Zambarakji H, Pryce G, Baker D, Adamson P, Calder V, Greenwood J (2005) Suppression of autoimmune retinal disease by lovastatin does not require Th2 cytokine induction. J Immunol 174:2327-2335
55. Geissmann F, Jung S, Littman DR (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19:71-82
56. Giebel SJ, Menicucci G, McGuire PG, Das A (2005) Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier. Lab Invest 85:597-607
57. Greenwood J (1991) Mechanisms of blood-brain barrier breakdown. Neuroradiology 33:95-100
58. Greenwood J, Calder VL (1993) Lymphocyte migration through cultured endothelial cell monolayers derived from the blood-retinal barrier. Immunology 80:401-406
59. Greenwood J, Amos CL, Walters CE, Couraud PO, Lyck R, Engelhardt B, Adamson P (2003) Intracellular domain of brain endothelial intercellular adhesion molecule-1 is essential for T lymphocyte-mediated signaling and migration. J Immunol 171:2099-2108
60. Greenwood J, Howes R, Lightman S (1994) The blood-retinal barrier in experimental autoimmune uveoretinitis. Leukocyte interactions and functional damage. Lab Invest 70:39-52
61. Greenwood J, Wang Y, Calder VL (1995) Lymphocyte adhesion and transendothelial migration in the central nervous system: the role of LFA-1, ICAM-1, VLA-4 and VCAM-1. off. Immunology 86:408-415
62. Haseloff RF, Blasig IE, Bauer HC, Bauer H (2005) In search of the astrocytic factor(s) modulating blood-brain barrier functions in brain capillary endothelial cells in vitro. Cell Mol Neurobiol 25:25-39
63. Hawkins BT, Davis TP (2005) The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 57:173-185
64. Heil M, Clauss M, Suzuki K, Buschmann IR, Willuweit A, Fischer S, Schaper W (2000) Vascular endothelial growth factor (VEGF) stimulates monocyte migration through endothelial monolayers via increased integrin expression. Eur J Cell Biol 79:850-857
65. Hickey WF (2001) Basic principles of immunological surveillance of the normal central nervous system. Glia 36:118-124
66. Hickey WF, Hsu BL, Kimura H (1991) T-lymphocyte entry into the central nervous system. J Neurosci Res 28:254-260
67. Hoey S, Grabowski PS, Ralston SH, Forrester JV, Liversidge J (1997) Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-gamma-dependent mechanism. J Immunol 159:5132-5142
68. Howard OMZ, Dong HF, Su SB, Caspi RR, Chen X, Plotz P, Oppenheim JJ (2005) Autoantigens signal through chemokine receptors: uveitis antigens induce CXCR3- and CXCR5-expressing lymphocytes and immature dendritic cells to migrate. Blood 105:4207-4214
69. Ishida S, Usui T, Yamashiro K, Kaji Y, Ahmed E, Carrasquillo KG, Amano S, Hida T, Oguchi Y, Adamis AP (2003) VEGF164 is proinflammatory in the diabetic retina. Invest Ophthalmol Vis Sci 44:2155-2162
70. Ishida S, Usui T, Yamashiro K, Kaji Y, Amano S, Ogura Y, Hida T, Oguchi Y, Ambati J, Miller JW, Gragoudas ES, Ng YS, D'Amore PA, Shima DT, Adamis AP (2003) VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization. J Exp Med 198:483-489
71. Janeway CA, Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20:197-216
72. Jha P, Bora PS, Bora NS (2007) The role of complement system in ocular diseases including uveitis and macular degeneration. Mol Immunol 44:3901-3908
73. Johnson KP (2007) Natalizumab (Tysabri) treatment for relapsing multiple sclerosis. Neurologist 13:182-187
74. Johnston B, Butcher EC (2002) Chemokines in rapid leukocyte adhesion triggering and migration. Semin Immunol 14:83-92
75. Joshi A, Bauer R, Kuebler P, White M, Leddy C, Compton P, Garovoy M, Kwon P, Walicke P, Dedrick R (2006) An overview of the pharmacokinetics and pharmacodynamics of efalizumab: a monoclonal antibody approved for use in psoriasis. J Clin Pharmacol 46:10-20
76. Kastelan S, Zjacic-Rotkvic V, Kastelan Z (2007) Could diabetic retinopathy be an autoimmune disease? Med Hypotheses 68:1016-1018
77. Kenakin T, Onaran O (2002) The ligand paradox between affinity and efficacy: can you be there and not make a difference? Trends Pharmacol Sci 23:275-280
78. Kim M, Carman CV, Springer TA (2003) Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science 301:1720-1725
79. Kuppner MC, Liversidge J, McKillop-Smith S, Lumsden L, Forrester JV (1993) Adhesion molecule expression in acute and fibrotic sympathetic ophthalmia. Curr Eye Res 12:923-934
80. Leal EC, Manivannan A, Hosoya K, Terasaki T, Cunha-Vaz J, Ambrosio AF, Forrester JV (2007) Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy. Invest Ophthalmol Vis Sci 48:5257-5265
81. Lesnik P, Haskell CA, Charo IF (2003) Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis. J Clin Invest 111:333-340
82. Ley K, Laudanna C, Cybulsky MI, Nourshargh S (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7:678-689
83. Liversidge J, Forrester JV (1988) Experimental autoimmune uveitis (EAU): immunophenotypic analysis of inflammatory cells in chorio retinal lesions. Curr Eye Res 7:1231-1241
84. Liversidge J, Forrester JV (1999) Regulation of immune responses by the retinal pigment epithelium. In: Marmor MF, Wolfensberger TJ (eds) Retinal pigment epithelium, current aspects of function and disease. Oxford University Press, Oxford, pp 511-527
85. Liversidge J, Sewell HF, Forrester JV (1990) Interactions between lymphocytes and cells of the blood-retina barrier: mechanisms of T lymphocyte adhesion to human retinal capillary endothelial cells and retinal pigment epithelial cells in vitro. Immunology 71:390-396
86. Luna JD, Chan CC, Derevjanik NL, Mahlow J, Chiu C, Peng B, Tobe T, Campochiaro PA, Vinores SA (1997) Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta-mediated breakdown. J Neurosci Res 49:268-280
87. Luscinskas FW, Ma S, Nusrat A, Parkos CA, Shaw SK (2002) The role of endothelial cell lateral junctions during leukocyte trafficking. Immunol Rev 186:57-67
88. Maharaj AS, D'Amore PA (2007) Roles for VEGF in the adult. Microvasc Res 74:100-113
89. Maly P, Thall A, Petryniak B, Rogers CE, Smith PL, Marks RM, Kelly RJ, Gersten KM, Cheng G, Saunders TL, Camper SA, Camphausen RT, Sullivan FX, Isogai Y, Hindsgaul O, von Andrian UH, Lowe JB (1996) The alpha(1,3)fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell 86:643-653
90. Mandell KJ, Berglin L, Severson EA, Edelhauser HF, Parkos CA (2007) Expression of JAM-A in the human corneal endothelium and retinal pigment epithelium: localization and evidence for role in barrier function. Invest Ophthalmol Vis Sci 48:3928-3936
91. Mantovani A (1999) The chemokine system: redundancy for robust outputs. Immunol Today 20:254-257
92. Mantovani A, Bonecchi R, Locati M (2006) Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol 6:907-918
93. McMenamin PG, Forrester JV, Steptoe RJ, Dua HS (1992) Ultrastructural pathology of experimental autoimmune uveitis. Quantitative evidence of activation and possible high endothelial venule-like changes in retinal vascular endothelium. Lab Invest 67:42-55
94. 2 and monoclonal antibody to lymphocyte function-associated antigen-1 differentially inhibit migration of T lymphocytes across microvascular retinal endothelial cells in rat. Immunology 88:471-477
95. Middleton J, Neil S, Wintle J, Clark-Lewis I, Moore H, Lam C, Auer M, Hub E, Rot A (1997) Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 91:385-395
96. Middleton J, Patterson AM, Gardner L, Schmutz C, Ashton BA (2002) Leukocyte extravasation: chemokine transport and presentation by the endothelium. Blood 100:3853-3860
97. Moore TC, Moore JE, Kaji Y, Frizzell N, Usui T, Poulaki V, Campbell IL, Stitt AW, Gardiner TA, Archer DB, Adamis AP (2003) The role of advanced glycation end products in retinal microvascular leukostasis. Invest Ophthalmol Vis Sci 44:4457-4464
98. Muller WA, Randolph GJ (1999) Migration of leukocytes across endothelium and beyond: molecules involved in the transmigration and fate of monocytes. J Leukoc Biol 66:698-704
99. Niederkorn JY (2006) See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Immunol 7:354-359
100. Norman MU, Kubes P (2005) Therapeutic intervention in inflammatory diseases: a time and place for anti-adhesion therapy. Microcirculation 12:91-98
101. Oppenheim JJ, Dong HF, Plotz P, Caspi RR, Dykstra M, Pierce S, Martin R, Carlos C, Finn O, Koul O, Howard OM (2005) Autoantigens act as tissue-specific chemoattractants. J Leukoc Biol 77:854-861
102. Pachter JS, De Vries HE, Fabry Z (2003) The blood-brain barrier and its role in immune privilege in the central nervous system. J Neuropathol Exp Neurol 62:593-604
103. Prendergast RA, Iliff CE, Coskuncan NM, Caspi RR, Sartani G, Tarrant TK, Lutty GA, McLeod DS (1998) T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci 39:754-762
104. Proudfoot AEI, Handel TM, Johnson Z, Lau EK, LiWang P, Clark-Lewis I, Borlat F, Wells TNC, Kosco-Vilbois MH (2003) Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc Natl Acad Sci USA 100:1885-1890
105. Qaum T, Xu Q, Joussen AM, Clemens MW, Qin W, Miyamoto K, Hassessian H, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis AP (2001) VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci 42:2408-2413
106. Quinones MP, Ahuja SK, Jimenez F, Schaefer J, Garavito E, Rao A, Chenaux G, Reddick RL, Kuziel WA, Ahuja SS (2004) Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis. J Clin Invest 113:856-866
107. Rollins BJ (1997) Chemokines. Blood 90:909-928
108. Rosen SD (2004) Ligands for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol 22:129-156
109. Rossi D, Zlotnik A (2000) The biology of chemokines and their receptors. Annu Rev Immunol 18:217-243
110. Rot A (2005) Contribution of Duffy antigen to chemokine function. Cytokine Growth Factor Rev 16:687-694
111. Rot A, von Andrian UH (2004) Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 22:891-928
112. Serbina NV, Pamer EG (2006) Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 7:311-317
113. Shaw SK, Bamba PS, Perkins BN, Luscinskas FW (2001) Real-time imaging of vascular endothelial-cadherin during leukocyte transmigration across endothelium. J Immunol 167:2323-2330
114. Silver PB, Chan C-C, Wiggert B, Caspi RR (1999) The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10. A mice develop EAU and Th1 responses to IRBP without pertussis treatment. Invest Ophthalmol Vis Sci 40:2898-2905
115. Smiley ST, King JA, Hancock WW (2001) Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 167:2887-2894
116. Song L, Pachter JS (2004) Monocyte chemoattractant protein-1 alters expression of tight junction-associated proteins in brain microvascular endothelial cells. Microvasc Res 67:78-89
117. Sonoda KH, Sasa Y, Qiao H, Tsutsumi C, Hisatomi T, Komiyama S, Kubota T, Sakamoto T, Kawano YI, Ishibashi T (2003) Immunoregulatory role of ocular macrophages. The macrophages produce RANTES to suppress experimental autoimmune uveitis. J Immunol 171:2652-2659
118. Soriano SG, Amaravadi LS, Wang YF, Zhou H, Yu GX, Tonra JR, Fairchild-Huntress V, Fang Q, Dunmore JH, Huszar D, Pan Y (2002) Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury. J Neuroimmunol 125:59-65
119. Stein JV, Cheng G, Stockton BM, Fors BP, Butcher EC, von Andrian UH (1999) L-selectin-mediated leukocyte adhesion in vivo: microvillous distribution determines tethering efficiency, but not rolling velocity. J Exp Med 189:37-50
120. Streilein JW (2003) Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation. J Leukoc Biol 74:179-185
121. Streilein JW, Ksander BR, Taylor AW (1997) Immune deviation in relation to ocular immune privilege. J Immunol 158:3557-3560
122. Sun B, Rizzo LV, Sun S-H, Chan C-C, Wiggert B, Wilder RL, Caspi RR (1997) Genetic susceptibility to experimental autoimmune uveitis involves more than a predisposition to generate a T Helper-1-like or a T Helper-2-like response. J Immunol 159:1004-1011
123. Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, Llodra J, Garin A, Liu JH, Mack M, van Rooijen N, Lira SA, Habenicht AJ, Randolph GJ (2007) Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 117:185-194
124. Tanaka Y, Adams DH, Shaw S (1993) Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol Today 14:111-115
125. Tsou CL, Peters W, Si Y, Slaymaker S, Aslanian AM, Weisberg SP, Mack M, Charo IF (2007) Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest 117:902-909
126. Vestweber D (2000) Molecular mechanisms that control endothelial cell contacts. J Pathol 190:281-291
127. + T cells. Blood 97:1144-1146
128. Wilkinson-Berka JL (2004) Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide. Curr Pharm Des 10:3331-3348
129. Worthylake RA, Burridge K (2001) Leukocyte transendothelial migration: orchestrating the underlying molecular machinery. Curr Opin Cell Biol 13:569-577
130. Xanthou G, Duchesnes CE, Williams TJ, Pease JE (2003) CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11. Eur J Immunol 33:2241-2250
131. Xu H, Manivannan A, Goatman K, Liversidge J, Sharp PF, Forrester JV, Crane I (2002a) Improved leukocyte tracking in mouse retinal and choroidal circulation. Exp Eye Res 74:403-410
132. Xu H, Chen M, Mayer EJ, Forrester JV, Dick AD (2007a) Turnover of resident retinal microglia in the normal adult mouse. Glia 55:1189-1198
133. Xu H, Dawson R, Crane IJ, Liversidge J (2005a) Leukocyte diapedesis in vivo induces transient loss of tight junction protein at the blood-retina barrier. Invest Ophthalmol Vis Sci 46:2487-2494
134. Xu H, Dawson R, Forrester JV, Liversidge J (2007b) Identification of novel dendritic cell populations in normal mouse retina. Invest Ophthalmol Vis Sci 48:1701-1710
135. Xu H, Forrester JV, Liversidge J, Crane IJ (2003a) Leukocyte trafficking in experimental autoimmune uveitis: breakdown of blood-retinal barrier and upregulation of cellular adhesion molecules. Invest Ophthalmol Vis Sci 44:226-234
136. Xu H, Manivannan A, Dawson R, Crane IJ, Mack M, Sharp P, Liversidge J (2005b) Differentiation to the CCR2+ inflammatory phenotype in vivo is a constitutive, time-limited property of blood monocytes and is independent of local inflammatory mediators. J Immunol 175:6915-6923
137. Xu H, Manivannan A, Goatman KA, Jiang HR, Liversidge J, Sharp PF, Forrester JV, Crane IJ (2004a) Reduction in shear stress, activation of the endothelium, and leukocyte priming are all required for leukocyte passage across the blood-retina barrier. J Leukoc Biol 75:224-232
138. Xu H, Manivannan A, Jiang HR, Liversidge J, Sharp PF, Forrester JV, Crane IJ (2004b) Recruitment of IFN-gamma-producing (Th1-like) cells into the inflamed retina in vivo is preferentially regulated by P-selectin glycoprotein ligand 1:P/E-selectin interactions. J Immunol 172:3215-3224
139. Xu H, Manivannan A, Liversidge J, Sharp PF, Forrester JV, Crane IJ (2003b) Requirements for passage of T lymphocytes across non-inflamed retinal microvessels. J Neuroimmunol 142:47-57
140. Xu H, Manivannan A, Liversidge J, Sharp PF, Forrester JV, Crane IJ (2002b) Involvement of CD44 in leukocyte trafficking at the blood-retinal barrier. J Leukoc Biol 72:1133-1141
141. Yonekawa K, Harlan IJ (2005) Targeting leukocyte integrins in human diseases. J Leukoc Biol 77:129-140
142. Zernecke A, Weber KSC, Erwig LP, Kluth DC, Schroppel B, Rees AJ, Weber C (2001) Combinatorial model of chemokine involvement in glomerular monocyte recruitment: role of CXC chemokine receptor 2 in infiltration during nephrotoxic nephritis. J Immunol 166:5755-5762
143. Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12:121-127